Trial of Autologous Mesenchymal Stem Cells
Trial of Autologous Mesenchymal Stem Cells Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis Sara Llufriu,#1 María Sepúlveda,#1 Yolanda Blanco,1 Pedro Marín,2 Beatriz Moreno,1 Joan Berenguer,3 Iñigo Gabilondo,1 Eloy Martínez-Heras,1 Nuria Sola-Valls,1 Joan-Albert Arnaiz,4 Enrique J. Andreu,5 Begoña Fernández,1 Santi Bullich,1 Bernardo Sánchez-Dalmau,1,6 Francesc Graus,1 Pablo Villoslada,1 and Albert Saiz1,* […]
Date: August 25th, 2022